Archives
-
IDH2, α-KG and HIF-1α in Colorectal Cancer
2026-10-12
A 2024 study examines how IDH2-associated metabolic reprogramming may support colorectal cancer progression through α-ketoglutarate availability, mitochondrial energy production, glycolysis and HIF-1A signaling. The findings support a mechanistic model, but the evidence remains preclinical and does not establish clinical benefit or validate any specific metabolic product.
-
Bazedoxifene and IL-6/GP130 Signaling in Cancer
2026-10-10
Shi and colleagues present a literature-based assessment of bazedoxifene as a potential anticancer agent that disrupts IL-6/GP130 signaling, a pathway linked to tumor survival, proliferation, inflammation, and treatment resistance. The review’s main translational contribution is to connect drug repurposing with a mechanistic strategy focused on GP130-associated signaling while emphasizing that current evidence remains largely preclinical and requires disease-specific validation.
-
Rucaparib (AG-014699): PARP1 Evidence Guide
2026-10-09
Rucaparib, also called AG-014699, is a PARP inhibitor used in DNA damage response and cancer biology research. Evidence supports PARP1 catalytic inhibition and context-dependent DNA-repair vulnerabilities, while transport, assay provenance, model selection, and the preclinical status of some findings limit broad interpretation.
-
Artemisia argyi Oil and Brown Fat Thermogenesis
2026-10-09
A 2025 npj Science of Food study reports that Artemisia argyi oil reduced high-fat diet-associated weight gain and adiposity in a preclinical model while improving insulin sensitivity. Its central mechanistic contribution is the proposed connection between brown adipose tissue thermogenesis, Ucp1 transcription, ZFP516 expression, and ZFP516–LSD1 interaction.
-
PKH26 Red Fluorescent Cell Linker Kit Overview
2026-10-08
A catalog-level overview of the PKH26 Red Fluorescent Cell Linker Kit, including its documented identity, intended conceptual scope, and evidence limitations.
-
PVX Nanoparticles for RNA Gene Delivery
2026-10-08
A 2025 Scientific Reports study presents potato virus X coat protein as a modular scaffold for assembling nucleoprotein nanoparticles around mRNA and circRNA. The work demonstrates tunable particle architectures and reporter-protein expression in eukaryotic cells, while leaving important questions about biodistribution, safety, durability, and therapeutic performance unresolved.
-
Macrophage MERTK in Pressure Overload Heart Failure
2026-10-07
A 2025 study identifies macrophage MERTK as an unexpected amplifier of pressure overload-induced cardiac hypertrophy and heart failure. Its evidence connects efferocytosis of apoptotic cardiomyocytes with mitochondrial RNA–TLR3–IFN-β signaling, revealing a context-dependent inflammatory mechanism that may refine cardiovascular remodeling research.
-
Influenza Hemagglutinin (HA) Peptide: Evidence Overview
2026-10-07
A source-grounded overview of the HA tag peptide as a molecular biology reagent, with conceptual applications in protein detection and affinity studies, alongside a critical assessment of recent findings on PRKX, PD-L1 and immunotherapy resistance in gastric cancer.
-
Removing Pollen Interference in EEM Bioaerosol Detection
2026-10-06
Zhang et al. investigated how pollen fluorescence can confound the classification of hazardous bioaerosol components using excitation–emission matrix spectroscopy. Their combination of spectral transformation and random forest classification improved the reported accuracy to 89.24%, while also clarifying the limits of fluorescence-based recognition in complex environmental samples.
-
ABT-263 and Senolytic Apoptosis Research
2026-10-06
ABT-263, also known as Navitoclax, is a Bcl-2-family inhibitor used in cancer biology and apoptosis research. This overview examines its relevance to therapy-induced senescence, emphasizing findings from a prostate cancer study, evidence strength, conceptual applications, and limits on translating cell-model results into clinical conclusions.
-
Forskolin and HSV-1 Reactivation: Five Questions
2026-10-05
A source-grounded overview of Forskolin as an adenylate cyclase activator, examining its proposed cAMP principle, evidence from a human sensory-neuron model of HSV-1 latency, and the limits of interpreting in vitro reactivation findings.
-
High Yield T7 Biotin16 RNA Labeling Kit
2026-10-05
The High Yield T7 Biotin16 RNA Labeling Kit is cataloged as K1082, but the supplied dossier does not provide composition, reaction conditions, yield data, or validated application performance. Its likely role is as a source of biotin-labeled RNA for detection or affinity assays, while the cited study independently connects SMN–METTL14 regulation with RNA m6A homeostasis.
-
Full-Length αvβ3 Integrin Dynamics by Cryo-EM
2026-10-04
The reference study uses high-resolution cryo-EM to reveal six apo conformations and five ligand-bound states of full-length human αvβ3 integrin, including previously uncharacterized intermediates. Its findings support a continuum model of integrin activation and show that CWHM-12 can stabilize distinct inhibited conformational states, offering a structural basis for more selective inhibitor design.
-
Angiotensin II Product Overview
2026-10-03
Angiotensin II (SKU A1042; CAS 4474-91-3) is an endogenous octapeptide listed by APExBIO for conceptual cardiovascular and vascular research applications. No matched paper evidence was available for this product entry.
-
Quaternization Redirects mRNA Delivery to the Lung
2026-10-02
The reference study shows that N-quaternization of a lipid-like carrier can convert systemic mRNA biodistribution from spleen preference to highly selective lung delivery. Its findings link a relatively simple head-group modification with improved in vitro delivery, pulmonary immune-cell uptake, and more than one year of ambient storage stability.